[
    [
        {
            "time": "2023-03-03",
            "original_text": "健帆生物发生大宗交易成交折价率23.68%",
            "features": {
                "keywords": [
                    "健帆生物",
                    "大宗交易",
                    "折价率"
                ],
                "sentiment_score": -0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医疗健康"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "健帆生物发生大宗交易成交折价率23.68%",
                "Correlation": 10,
                "Sentiment": 4,
                "Importance": 7,
                "Impact": 7,
                "Duration": 5,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "2023-03-03",
            "original_text": "A股共发生178宗大宗交易成交65.51亿元（3月3日）",
            "features": {
                "keywords": [
                    "A股",
                    "大宗交易",
                    "成交额"
                ],
                "sentiment_score": 0.2,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "全市场"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "A股共发生178宗大宗交易成交65.51亿元（3月3日）",
                "Correlation": 3,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 4,
                "Duration": 4,
                "Entity_Density": 2,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 5,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-03-03",
            "original_text": "东吴证券给予健帆生物买入评级，股权激励方案发布，长期增长确定性强",
            "features": {
                "keywords": [
                    "东吴证券",
                    "健帆生物",
                    "买入评级",
                    "股权激励",
                    "长期增长"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医疗健康"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "东吴证券给予健帆生物买入评级，股权激励方案发布，长期增长确定性强",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 8,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2023-03-03",
            "original_text": "安信证券维持健帆生物买入评级：第五次股权激励计划发布，业绩指引再提速",
            "features": {
                "keywords": [
                    "安信证券",
                    "健帆生物",
                    "买入评级",
                    "股权激励",
                    "业绩指引"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医疗健康"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "安信证券维持健帆生物买入评级：第五次股权激励计划发布，业绩指引再提速",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        },
        {
            "time": "2023-03-03",
            "original_text": "健帆生物现1笔大宗交易共成交326.09万元",
            "features": {
                "keywords": [
                    "健帆生物",
                    "大宗交易",
                    "成交额"
                ],
                "sentiment_score": -0.3,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医疗健康"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "健帆生物现1笔大宗交易共成交326.09万元",
                "Correlation": 9,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 6,
                "Duration": 4,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-03-03",
            "original_text": "健帆生物今日大宗交易成交5.33万股，成交价61.18元折价23.68%",
            "features": {
                "keywords": [
                    "健帆生物",
                    "大宗交易",
                    "成交价",
                    "折价率"
                ],
                "sentiment_score": -0.45,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医疗健康"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "健帆生物今日大宗交易成交5.33万股，成交价61.18元折价23.68%",
                "Correlation": 10,
                "Sentiment": 4,
                "Importance": 7,
                "Impact": 7,
                "Duration": 5,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 10
            }
        }
    ]
]